2-fluoro-2-deoxy-d-glucose
Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer
7
Detectability of Hypometabolic Regions in Mild Alzheimer Disease: Function of Time after the Injection of 2 [Fluorine 18] Fluoro 2 Deoxy d Glucose
5
2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
9
Incidentalomas of the prostate detected by 18 fluoro 2 deoxy D glucose positron emission tomography/computed tomography
12
Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography
11
Targeting adipose tissue
11
Spatial relationship of 2-deoxy-2-[18F]-fluoro-D-glucose positron emission tomography and magnetic resonance diffusion imaging metrics in cervical cancer
10
Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade
5
Assessment of the kidney function parameters split function, mean transit time, and outflow efficiency using dynamic FDG-PET/MRI in healthy subjects
12
Clinical review: Lung imaging in acute respiratory distress syndrome patients an update
13
Standardised uptake values of 2 deoxy 2 [18F]fluoro d glucose using PET/CT in normal cats
9
Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate
7
Cholangiocarcinoma associated with limbic encephalitis and early cerebral abnormalities detected by 2 deoxy 2 [fluorine 18]fluoro d glucose integrated with computed tomography positron emission tomography: a case report
6
Chronic expanding hematoma with a significantly high fluorodeoxyglucose uptake on 18F fluorodeoxyglucose positron emission tomography, mimicking a malignant soft tissue tumor: a case report
5
Positron emission tomography agent 2 deoxy 2 [18F]fluoro D glucose has a therapeutic potential in breast cancer
7
Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model
9
Optimal 2-[18F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
7
Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
10
THE EFFECT OF USING PET CT FUSION ON TARGET VOLUME DELINEATION AND DOSE TO ORGANS AT RISK IN 3D RADIOTHERAPY PLANNING OF PATIENTS WITH NSSLC
6
THE EFFECT OF 2 DEOXY D GLUCOSE INFUSIONS ON LIPID AND CARBOHYDRATE METABOLISM IN MAN
7